Re:To Sell a $1,000 Pill for $10 Without Losing Money
by MichalSikora on Wednesday March 02, 2016 @04:00AM
(#11208854)
Yes, that could be also good explanation. I assume also that China, India etc. have completely different genetic population than europe populationes. This is important at clinical trials or bioequivalence study because some drugs substances could work differently for peoples form Asia and Europe. Pharma companies run trailes e.g in China and sell drugs only for regional area (because it work) this drug will be ineffective in Europe or could to do more damage.
The other concern emerging economies like China have is they are already developing their own brand name/patented drugs. If they don't respect the US/EU patents, they can't really complain when the US/EU doesn't respect theirs. The US market makes up almost 2/3 of the western drug market, so it would be a huge lose for China.